Life Science Technical Accounting Update 2025

From Gross to Net Estimates and Accruals to Preparing for an IPO to Government Pricing for Biotechs to Revenue Recognition examples and latest updates, this conference will address the latest developments in key areas. You'll hear from experts at Deloitte, Ernst and Young, Effectus Group, life science analysts and your industry counterparts.
LEARNING OBJECTIVES:
Understand the latest accounting changes in key areas
Recognize the timelines and key factors affecting the life science industry
Begin to assess the effects of these standards on your company or clients
REGISTRATION INFORMATION:
Cost: $545 (save $150 off the regular price of $695 if you register by August 15th).
This event will run 8:45-4:55p (Pacific Time) each day.

REGISTER NOW »

Register any one of three ways:
1. Register online using a credit card and click the orange button
2. Register by phone at (610) 789-3110 
3. Email your contact info to be invoiced to [email protected]

Edit
Agenda: DAY 1
8:45 10:10 Recent Accounting Trends in the Life Science Industry
Collaboration Accounting
Grants
Inbound Licenses
Accounting for Financing Arrangements
10:10 10:20    Break
10:20 11:30    Tax Update
Latest legislative developments
Key Tax Proposals
Build Back Better Act Observations
Possible timing and other legislative priorities
11:30 12:15 Lunch Break
12:15 1:35 Revenue Recognition: Evolving Issues - Life Sciences
Scope of Contract
Performance Obligations
Nature of promise: sales of points
Collaboration agreements
Sales using third party platforms
Gross vs Net
Counterparty Perspective
1:35 1:50 Break
1:50 3:15 Regulatory Update
Cybersecurity Risk Management, Strategy Governance and Incident Disclosure
Market Trends
SEC Requirements Explained
The Framework
Disclosure Examples
Financial Accounting Update
FASB Project Update
ASUs
Issues on the horizon
3:15 3:25 Break
3:25 4:45 SOX and Internal Controls Update
Risk Assesment
Management Review Controls
Information Used in Controls
IT - General Controls Considerations
Edit
Agenda: DAY 2
8:45 10:00 GenAI Use Cases in Accounting and Finance
Examine risks and myths
Explore AI use cases
Define steps for adopting AI
Practical use cases for today
Exciting use cases for tomorrow
10:00 10:15    Break
10:15 11:45    Gross to Net
Introduction and Overview
Industry View
Estimation Methodology
Approaching Launch
Key Challenges
SEC Comments
Close and Financial Reporting
GTN Hot Topics Discussion
Inventory Accounting Refresh
11:45 12:20 Lunch Break
12:20 1:40 Financing Trends
Royalty Monetization
Convertible Debt
Accounting Considerations
When should companies consider convertible debt?
Convertible structure in the life science financing cycle
Changes of control, tax implications, size, maturity and other questions
1:40 1:50 Break
1:50 3:10 Accounting for R and D and Clinical Trials
R and D Funding Arrangements
R and D Cost Classifications
Other Intangible Assets
SEC Comment Letter Trends
3:10 3:20 Break
3:20 4:40 ESG
ESG Landscape: Regulatory Developments
Operationalizing ESG and Sustainability
Disclosure Trends in Life Sciences Industry
Taking Action